IL128412A0 - Hiv p-17 peptide fragment, compositions containing and methods for producing and using same - Google Patents

Hiv p-17 peptide fragment, compositions containing and methods for producing and using same

Info

Publication number
IL128412A0
IL128412A0 IL12841297A IL12841297A IL128412A0 IL 128412 A0 IL128412 A0 IL 128412A0 IL 12841297 A IL12841297 A IL 12841297A IL 12841297 A IL12841297 A IL 12841297A IL 128412 A0 IL128412 A0 IL 128412A0
Authority
IL
Israel
Prior art keywords
hiv
producing
methods
same
compositions containing
Prior art date
Application number
IL12841297A
Other languages
English (en)
Original Assignee
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/695,301 external-priority patent/US6093400A/en
Application filed by Viral Technologies Inc filed Critical Viral Technologies Inc
Publication of IL128412A0 publication Critical patent/IL128412A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12841297A 1996-08-09 1997-08-08 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same IL128412A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/695,301 US6093400A (en) 1996-08-09 1996-08-09 Modified HGP-30 peptides, conjugates, compositions and methods of use
US08/824,800 US6111068A (en) 1996-08-09 1997-03-26 HIV-1 p-17 peptide fragments, compositions containing and methods for producing and using same
PCT/US1997/013900 WO1998006429A1 (en) 1996-08-09 1997-08-08 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same

Publications (1)

Publication Number Publication Date
IL128412A0 true IL128412A0 (en) 2000-01-31

Family

ID=27105549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12841297A IL128412A0 (en) 1996-08-09 1997-08-08 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same

Country Status (8)

Country Link
US (1) US6258945B1 (xx)
EP (1) EP0969864A1 (xx)
JP (1) JP2001505763A (xx)
CN (1) CN1233187A (xx)
AU (1) AU731367B2 (xx)
CA (1) CA2262432A1 (xx)
IL (1) IL128412A0 (xx)
WO (1) WO1998006429A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60043856D1 (de) 1999-12-23 2010-04-01 Medical Res Council Verbesserungen in oder in bezug auf immunantworten gegen hiv
EP1311548A4 (en) * 2000-05-24 2005-01-19 Cel Sci Corp T-CELL BINDING LIGANDENEPEPTIDES, PEPTIDE CONSTRUCTS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS
GB0716494D0 (en) * 2007-08-23 2007-10-03 Isis Innovation HIV-2 antigenic peptides
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227169B1 (en) 1985-12-17 1993-03-17 Akzo N.V. Immunochemical reagent
US4983387A (en) * 1986-05-19 1991-01-08 Viral Technologies Inc. HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
NZ220200A (en) 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
US4966806A (en) 1986-12-16 1990-10-30 Foster Miller, Inc. Film-based structural components with controlled coefficient of thermal expansion
EP0330359A3 (en) 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GB2273710B (en) 1990-01-05 1994-09-28 Medical Res Council Peptide fragments of HIV
US5556744A (en) 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization

Also Published As

Publication number Publication date
JP2001505763A (ja) 2001-05-08
WO1998006429A1 (en) 1998-02-19
AU731367B2 (en) 2001-03-29
CN1233187A (zh) 1999-10-27
AU3910997A (en) 1998-03-06
EP0969864A1 (en) 2000-01-12
CA2262432A1 (en) 1998-02-19
US6258945B1 (en) 2001-07-10

Similar Documents

Publication Publication Date Title
ZA978178B (en) Composition.
HK1019529A1 (en) Efficient output-request packet switch and method.
ZA961291B (en) Naphthyl compounds, intermediates, compositions, and methods.
ZA975261B (en) Composition.
ZA976815B (en) Vaccine composition.
IL125550A0 (en) 2-hetaroylcyclohexane-1,3-diones process for preparation and compositions containing them
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA976056B (en) Block former.
GB9706597D0 (en) Compositions,processes and uses
GB9608488D0 (en) Compositions, processes and uses
ZA977052B (en) HIV p-17 peptide fragment compositions containing and methods for producing and using same
AU9569098A (en) Improved block cipher method
IL128412A0 (en) Hiv p-17 peptide fragment, compositions containing and methods for producing and using same
GB9608489D0 (en) Compositions, processes and uses
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
ZA9710609B (en) Cement composition.
EP0968225A4 (en) NEW spsB
GB9608491D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses
GB9608493D0 (en) Compositions, processes and uses
GB9705849D0 (en) Compositions, processes and uses
AU4684297A (en) Aluminothermic mixture
GB9706322D0 (en) Compositions, processes and uses
AUPN966896A0 (en) Flavour enhancing process
ZA971775B (en) Novel method.